Cartalax 20mg research peptide vial — Cartilage Peptide Bioregulator

Images are for illustrative purposes only.

Cartilage

Cartalax

Cartilage Peptide Bioregulator

Cartalax is the tripeptide Ala-Glu-Asp (AED), molecular weight approximately 333 Da, developed from research into cartilage-derived peptide fractions. It is proposed to modulate gene expression in chondrocytes, the cell type responsible for synthesizing and maintaining cartilage extracellular matrix.

Cartalax occupies a distinctive structural position in the series: AED is the exact three-residue core that Epitalon (AEDG), Bronchogen (AEDL), Cardiogen (AEDR), and Cortagen (AEDP) each extend by a single fourth residue. Cartalax is that core on its own, making it the smallest member of the AED family and a frequent reference point in structure-activity discussions of the class. It is also the only bioregulator in the series oriented toward cartilage and joint tissue. In vitro and animal studies examine chondrocyte activity, proteoglycan and extracellular-matrix synthesis signaling, and joint-tissue gene expression.

Supplied as a lyophilized 10-vial 20mg kit for in vitro research use only.

$395
1
$395
per 10-vial kit
$1.98 / mg
Research Library
Cartalax Research Review →
Mechanism, evidence level & in vitro context
CategoryBioregulators
SequenceAla-Glu-Asp
Purity◆ ≥99%
FormLyophilized powder
Kit size10 vials
Per vial20mg
Storage−20°C recommended
UseResearch only
Certificate of Analysis
Available upon request. Custom and large batch orders include a batch-specific COA.
★  5+ kits, $20 off per kit
★  10+ kits, $30 off per kit
✓  Free shipping over $500 ($30 flat under)
✓  Discreet worldwide shipping in 2–3 business days
✓  Pay with crypto: BTC, USDC & USDT
View Cart → ← Back to Bioregulators
⚠ For in vitro research use only. Not for human or animal consumption. Not evaluated by the FDA. Read full disclaimer →
Common Questions
What is Cartalax?+
Cartalax is a Cartilage Peptide Bioregulator supplied for laboratory research. Cartilage-derived bioregulator studied in vitro for chondrocyte activity pathway modeling, extracellular matrix synthesis signaling, and joint tissue mechanism research.
What tissue does the Cartalax bioregulator target?+
Cartalax (Ala-Glu-Asp) is a cartilage-tissue peptide bioregulator studied for chondrocyte activity and extracellular-matrix synthesis in joint-tissue research.
What is the AED core sequence, and why does it matter for Cartalax?+
Cartalax is the tripeptide Ala-Glu-Asp (AED), about 333 Da. That sequence is the exact three-residue core that several other bioregulators extend by one residue: Epitalon (AEDG), Bronchogen (AEDL), Cardiogen (AEDR), and Cortagen (AEDP). Cartalax is that shared core on its own, making it the smallest member of the AED family and a common reference point in structure-activity discussion of the class. It is also the only compound in the series oriented toward cartilage.
What is lyophilized Cartalax, and how is it reconstituted?+
Cartalax is supplied as a lyophilized (freeze-dried) powder, a dehydrated form that keeps the peptide stable during shipping and storage. In the laboratory it is reconstituted (returned to liquid form) using a solvent such as bacteriostatic water, added slowly against the side of the vial, which is then swirled gently, never shaken, until the powder fully dissolves. All handling is for in vitro research use only.
How should Cartalax be stored?+
Store the lyophilized Cartalax powder at -20°C, protected from light and moisture, where it remains stable long-term. Once reconstituted, keep it refrigerated (2-8°C) and use it within the timeframe appropriate for your research protocol.
What is the purity of Cartalax, and how is it tested?+
Every batch of Cartalax is produced to a purity of 99% or higher. Purity and molecular identity are verified using standard analytical methods: high-performance liquid chromatography (HPLC) to measure purity, and mass spectrometry (MS) to confirm the peptide's molecular weight.